Aphria Inc. shares rallied more than 6% Tuesday, after a bullish analyst note and news that the company has achieved GMP status in the European Union, clearing the path for it to start selling medical cannabis to pharmacies in Germany and other countries. Read More...
Aphria Inc. shares rallied more than 6% Tuesday, after a bullish analyst note and news that the company has achieved GMP status in the European Union, clearing the path for it to start selling medical cannabis to pharmacies in Germany and other countries.
Add Comment